Biomarkers in Patients with Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

Article

This clinical trial is analyzing biomarkers in patients with respiratory tract dysplasia or lung cancer, head and neck cancer, or aerodigestive tract cancer and in normal volunteers.

Study Type: Observational

Age/Sex Requirement: None

Sponsor: University of Colorado at Denver and Health Sciences Center

Clinicaltrials.gov Identifier: NCT00900419

Purpose: To evaluate biomarkers in patients with respiratory tract dysplasia or lung cancer, head and neck cancer, or aerodigestive tract cancer and in normal volunteers. The primary outcome measure is genetic mutations or altered growth factor expression. The secondary outcome measure is the establishment of a tissue repository of normal and dysplastic respiratory epithelium.

Click here to access additional information from this third-party website.

Related Videos
3 KOLs are featured in this program.
3 KOLs are featured in this program.
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
A panel of 4 experts on HIV
A panel of 4 experts on HIV
Edward V Loftus, Jr, MD | Credit: Mayo Clinic
A panel of 4 experts on asthma
A panel of 4 experts on asthma
Katie Ross-Driscoll, PhD, MPH | Credit: Regenstrief Institute
© 2024 MJH Life Sciences

All rights reserved.